Skip to main content

Animations

MJFF Publications

1921 - 1930 of 6564 Results
Title
Year
  • Year
  • 2025
  • 2024
  • 2020
  • 2021
  • 2020
  • 2022
  • 2022
  • 2020
  • 2020
  • 2020
  • Summary Details
    OPEN
    Title: Multiomic analyses direct hypotheses for Creutzfeldt-Jakob disease risk genes
    Journal Name: Brain
    Publisher: Oxford University Press (OUP)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1093/brain/awaf032
    Citation Count: 9
  • Summary Details
    OPEN
    Title: Anti-Tetanus Vaccination Is Associated with Reduced Occurrence and Slower Progression of Parkinson’s Disease—A Retrospective Study
    Journal Name: Biomedicines
    Publisher: MDPI AG
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.3390/biomedicines12122687
    Citation Count: 0
  • Summary Details
    OPEN
    Title: Differential Associations of Apolipoprotein E ε4 Genotype With Attentional Abilities Across the Life Span of Individuals With Down Syndrome
    Journal Name: JAMA Network Open
    Publisher: American Medical Association (AMA)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by
    DOI - Digital Object Identifier: 10.1001/jamanetworkopen.2020.18221
    Citation Count: 11
  • Summary Details
    OPEN
    Title: Altered network stability in progressive supranuclear palsy
    Journal Name: Neurobiology of Aging
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by
    DOI - Digital Object Identifier: 10.1016/j.neurobiolaging.2021.07.007
    Citation Count: 15
  • Summary Details
    OPEN
    Title: Video-tutorial for the Movement Disorder Society criteria for progressive supranuclear palsy
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd, cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1016/j.parkreldis.2020.06.030
    Citation Count: 13
  • Summary Details
    OPEN
    Title: Editorial: Non-neuronal cell heterogeneity in the nervous system during health and disease
    Journal Name: Frontiers in Cellular Neuroscience
    Publisher: Frontiers Media SA
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by
    DOI - Digital Object Identifier: 10.3389/fncel.2022.1047296
    Citation Count: 1
  • Summary Details
    OPEN
    Title: Combining Multimodal Biomarkers to Guide Deep Brain Stimulation Programming in Parkinson Disease
    Journal Name: Neuromodulation: Technology at the Neural Interface
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by
    DOI - Digital Object Identifier: 10.1016/j.neurom.2022.01.017
    Citation Count: 57
  • Summary Details
    OPEN
    Title: Loss‐of‐Function Variants in HOPS Complex Genes VPS16 and VPS41 Cause Early Onset Dystonia Associated with Lysosomal Abnormalities
    Journal Name: Annals of Neurology
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by
    DOI - Digital Object Identifier: 10.1002/ana.25879
    Citation Count: 110
  • Summary Details
    OPEN
    Title: Genetic determinants of survival in progressive supranuclear palsy: a genome-wide association study
    Journal Name: The Lancet Neurology
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/s1474-4422(20)30394-x
    Citation Count: 120
  • Summary Details
    OPEN
    Title: Fibrillation and molecular characteristics are coherent with clinical and pathological features of 4-repeat tauopathy caused by MAPT variant G273R
    Journal Name: Neurobiology of Disease
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by
    DOI - Digital Object Identifier: 10.1016/j.nbd.2020.105079
    Citation Count: 8
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.